Teradyne (NASDAQ:TER – Get Free Report) was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Monday, MarketBeat Ratings reports.
A number of other brokerages have also commented on TER. Citigroup boosted their price objective on shares of Teradyne from $117.00 to $215.00 and gave the stock a “buy” rating in a research report on Wednesday, November 12th. Robert W. Baird set a $195.00 price target on shares of Teradyne in a research note on Friday, October 31st. JPMorgan Chase & Co. boosted their price target on shares of Teradyne from $122.00 to $190.00 and gave the stock a “neutral” rating in a research report on Thursday, October 30th. UBS Group increased their price objective on shares of Teradyne from $165.00 to $200.00 and gave the stock a “buy” rating in a research note on Thursday, October 30th. Finally, Stifel Nicolaus set a $225.00 target price on Teradyne and gave the company a “buy” rating in a research report on Tuesday, December 2nd. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $185.75.
View Our Latest Stock Analysis on Teradyne
Teradyne Price Performance
Teradyne (NASDAQ:TER – Get Free Report) last released its earnings results on Wednesday, October 29th. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. Teradyne had a return on equity of 18.04% and a net margin of 15.49%.The firm had revenue of $769.21 million for the quarter, compared to analysts’ expectations of $744.20 million. During the same quarter in the previous year, the business posted $0.90 EPS. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. Equities analysts expect that Teradyne will post 3.88 EPS for the current year.
Insider Transactions at Teradyne
In other news, CEO Gregory Stephen Smith sold 1,108 shares of the firm’s stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $201.31, for a total value of $223,051.48. Following the completion of the sale, the chief executive officer directly owned 93,409 shares of the company’s stock, valued at $18,804,165.79. This trade represents a 1.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders sold a total of 3,324 shares of company stock valued at $583,639 in the last 90 days. 0.16% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Teradyne
Several hedge funds have recently added to or reduced their stakes in the business. Root Financial Partners LLC acquired a new position in shares of Teradyne in the third quarter valued at $31,000. Davidson Capital Management Inc. acquired a new stake in shares of Teradyne during the 3rd quarter worth about $31,000. CYBER HORNET ETFs LLC bought a new stake in shares of Teradyne during the 2nd quarter worth about $35,000. Hemington Wealth Management grew its stake in Teradyne by 43.2% in the 3rd quarter. Hemington Wealth Management now owns 262 shares of the company’s stock valued at $36,000 after buying an additional 79 shares during the last quarter. Finally, KERR FINANCIAL PLANNING Corp acquired a new position in Teradyne in the 3rd quarter valued at about $41,000. Institutional investors and hedge funds own 99.77% of the company’s stock.
About Teradyne
Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.
The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.
Read More
- Five stocks we like better than Teradyne
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.
